{"disease":{"id":"breast-implant-revision","name":"breast implant revision"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01870869","title":"NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study","phase":"NA","overall_status":"TERMINATED","enrollment_count":1951,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT01785069","title":"Safety and Effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-filled X-Style and L-Style Breast Implants","phase":"NA","overall_status":"TERMINATED","enrollment_count":355,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT05437757","title":"Scaffold-guided Breast Surgery","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":19,"lead_sponsor_name":"BellaSeno Pty Ltd","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}